multiglandular


Also found in: Medical.

multiglandular

[‚məl·tə′glan·jə·lər]
(anatomy)
Of or pertaining to several glands.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
Mentioned in ?
References in periodicals archive ?
Given that the radiographic findings of IgG4-RS are nonspecific, differentiation of multiglandular and localized involvement from malignant lymphoma for multiglandular disease and salivary gland carcinoma for localized disease is challenging.
Furthermore, cystic adenomas were not associated with multiple endocrine neoplasia type 1 (MEN-1), multiglandular disease, or ectopic mediastinal parathyroid adenomas.
Together, they are responsible for the remaining 5% of saliva secreted in humans.[1],[2],[3],[4] It is considered that humans secrete approximately 0.5 L of saliva per day in response to stimulation of the sympathetic and parasympathetic sections of the autonomic nervous system.[3],[4],[5] Whole saliva is a multiglandular secretion complex consisting of gingival fluid, desquamated epithelial cells, microorganisms and products of their metabolism, food debris, leukocytes, and mucus from the nasal cavity and the larynx and pharynx.
Incidence of multiglandular disease in primary hyperparathyroidism determined by parathyroid hormone secretion.
Seventy-nine patients had a solitary parathyroid adenoma, one had parathyroid carcinoma, 12 had double adenomas, and two had multiglandular disease (one patient with three enlarged glands and one patient with four enlarged glands).
Pathologic examination of the surgical specimens showed multiglandular cystic parathyroid adenomas without evidence of parathyroid carcinoma (figure 2).
Hashimoto disease commonly links with autoimmunological diseases, such as: rheumatoid arthritis; Sjogren syndrome; psoriasis; celiakia; and multiglandular autoimmunological syndromes.
It is also important to remember the less common multiglandular involvement with PHPT.
(8) Minimally invasive surgery is currently the standard of care in patients with conclusive localisation studies (all indicating only one suspect gland at the same location) and no suspicion of multiglandular disease.